Granules Pharmaceuticals receives ANDA approval for amphetamine mixed salts ER capsules

Granules now have a total of 53 ANDA approvals from USFDA

U.S. District Court rules in favor of Merck in Sitagliptin Phosphate patent lawsuit

Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR

Benvic acquires specialty U.S. compounder Chemres

The ninth acquisition since 2018

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences

AMPEL BioSolutions' predicts drug options with RNA analytics & machine learning

Erectile dysfunction drugs help prevent death and complications due to heart disease

Huntington Medical Research Institutes present first-of-its-kind study examining impact of erectile dysfunction drugs on major adverse cardiovascular events and mortality

ZEISS announces USFDA clearance of the Quatera 700

The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise

BMSF names diversity in clinical trials training program after Robert A Winn

The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027

Medtronic announces first patient implants for bladder incontinence

Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy

Granules Pharmaceuticals clears USFDA audit

This is the sixth successful USFDA audit for this facility